 RED BANK, N.J. , Sept. 6, 2022 PRNewswire -- Provention Bio, Inc. Nasdaq: PRVB, a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate virtually in a corporate presentation at the H.C. 